<DOC>
	<DOCNO>NCT01771588</DOCNO>
	<brief_summary>It hypothesize growth preterm infant receive new human milk fortifier equal superior growth preterm infant receive currently market human milk fortifier low protein content .</brief_summary>
	<brief_title>Human Milk Fortifier - Growth Evaluation</brief_title>
	<detailed_description />
	<mesh_term>Premature Birth</mesh_term>
	<criteria>Birth weight ≤1500 g AND/OR gestational age ≤32 week ( determined maternal date , fetal ultrasound , Dubowitz/Ballard examination combination thereof ) Male female Tolerating enteral intake human milk , donor milk combination ≥100 mL/kg/d ≥ 24 h Subject anticipate receive human milk , donor milk combination ≥ 3 consecutive week achieve full fortification volume intake contain 150 180 mL/kg/d . Written inform consent obtain legal representative ( ) . Infants current systemic disease Infants history systemic disease Any congenital anomaly GI tract significantly interfere nutrition growth previous GI surgery . Small size gestational age ( SGA ) body weight ≦ 5th percentile gestational age . Infants diagnose inherent metabolic disease . Infants diagnose chromosomic disease . Receiving commercial formula supplementation breast milk . Receiving steroids time enrollment . Participation another nutritional clinical trial may affect outcome study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Month</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>